ATE532868T1 - Apoptose induzierende positivkontrolle für expressionsmodulationsexperimente - Google Patents
Apoptose induzierende positivkontrolle für expressionsmodulationsexperimenteInfo
- Publication number
- ATE532868T1 ATE532868T1 AT08866218T AT08866218T ATE532868T1 AT E532868 T1 ATE532868 T1 AT E532868T1 AT 08866218 T AT08866218 T AT 08866218T AT 08866218 T AT08866218 T AT 08866218T AT E532868 T1 ATE532868 T1 AT E532868T1
- Authority
- AT
- Austria
- Prior art keywords
- apoptosis
- positive control
- expression modulation
- inducing positive
- modulation experiments
- Prior art date
Links
- 239000013641 positive control Substances 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108020005345 3' Untranslated Regions Proteins 0.000 abstract 1
- 108091023045 Untranslated Region Proteins 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000003252 repetitive effect Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1732807P | 2007-12-28 | 2007-12-28 | |
| PCT/IB2008/003644 WO2009083790A2 (en) | 2007-12-28 | 2008-12-29 | 'apoptosis inducing positive control for expression modulating experiments' |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE532868T1 true ATE532868T1 (de) | 2011-11-15 |
Family
ID=40824794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08866218T ATE532868T1 (de) | 2007-12-28 | 2008-12-29 | Apoptose induzierende positivkontrolle für expressionsmodulationsexperimente |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8367320B2 (de) |
| EP (1) | EP2235180B1 (de) |
| AT (1) | ATE532868T1 (de) |
| WO (1) | WO2009083790A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2075333A1 (de) * | 2007-12-28 | 2009-07-01 | Qiagen GmbH | Positive Kontrollen für expressionsmodulierende Experimente |
| US20110136233A1 (en) * | 2008-08-05 | 2011-06-09 | Marina Biotech, Inc. | Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof |
| WO2011011700A2 (en) * | 2009-07-24 | 2011-01-27 | Curna, Inc. | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| WO2011139710A1 (en) * | 2010-04-26 | 2011-11-10 | Marina Biotech, Inc. | Nucleic acid compounds with conformationally restricted monomers and uses thereof |
| DE102011009470A1 (de) * | 2011-01-21 | 2012-08-09 | Friedrich-Schiller-Universität Jena | Biologisch wirksame Nukleotid-Moleküle zur gezielten Abtötung von Zellen, Verwendung derselben sowie Applikationskit |
| ES2855577T3 (es) * | 2011-03-30 | 2021-09-23 | Transine Therapeutics Ltd | Molécula de ácido nucleico funcional y uso de la misma |
| WO2012143427A1 (en) * | 2011-04-19 | 2012-10-26 | Santaris Pharma A/S | Anti polyomavirus compounds |
| DE102012203542B4 (de) * | 2012-03-07 | 2016-06-23 | Zf Friedrichshafen Ag | Verstellbares Dämpfventil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005014811A2 (en) * | 2003-08-08 | 2005-02-17 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| WO2005047477A2 (en) * | 2003-11-07 | 2005-05-26 | University Of Massachusetts | Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| EP2075333A1 (de) * | 2007-12-28 | 2009-07-01 | Qiagen GmbH | Positive Kontrollen für expressionsmodulierende Experimente |
-
2008
- 2008-12-29 US US12/810,281 patent/US8367320B2/en not_active Expired - Fee Related
- 2008-12-29 WO PCT/IB2008/003644 patent/WO2009083790A2/en not_active Ceased
- 2008-12-29 EP EP08866218A patent/EP2235180B1/de not_active Not-in-force
- 2008-12-29 AT AT08866218T patent/ATE532868T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| US8367320B2 (en) | 2013-02-05 |
| WO2009083790A2 (en) | 2009-07-09 |
| EP2235180B1 (de) | 2011-11-09 |
| EP2235180A2 (de) | 2010-10-06 |
| WO2009083790A8 (en) | 2010-02-18 |
| US20100285484A1 (en) | 2010-11-11 |
| WO2009083790A3 (en) | 2010-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE532868T1 (de) | Apoptose induzierende positivkontrolle für expressionsmodulationsexperimente | |
| PH12018500045A1 (en) | Compositions and methods for treating and diagnosing asthma | |
| CY1119509T1 (el) | Συνθεσεις και μεθοδοι για ρυθμιστες αποπτωσης | |
| GB201020995D0 (en) | Biological materials and uses thereof | |
| BR112013007862A2 (pt) | ácidos nucleicos manipulados e métodos de uso dos mesmos. | |
| BR112019000512A2 (pt) | anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, composição, métodos de tratamento de uma doença, para produzir um anticorpo biespecífico e para detectar se a reticulação entre as células que expressam cd40 e cd137 ocorre em uma amostra, uso de um anticorpo multiespecífico, e, kit | |
| BRPI0715718A2 (pt) | Anticorpo, métodos de triar para um anticorpo para o domínio extracelular de uma proteína prlr, de alterar sistematicamente anticorpos e triar para um anticorpo para o domínio extracelular de uma proteína prlr, de tratar um indivíduo que sofre de câncer, de alvejar uma célula tumoral que expressa prlr, de usar uma célula hospedeira, de identificar um indivíduo com necessidade de tratamento com um anticorpo anti-prlr, e de monitorar terapia de câncer em um indivíduo, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, composição farmacêutica, e, kit | |
| EA201491159A1 (ru) | Способы и композиции для анализа ahasl генов в пшенице | |
| EA201401319A1 (ru) | Способы и композиции рнк-специфической модификации днк-мишении рнк-специфической модуляции транскрипции | |
| BR122019022434B8 (pt) | método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular | |
| CY1116377T1 (el) | Αναστολεις της ανθρωπινης πρωτεϊνικης φωσφατασης της τυροσινης και μεθοδοι χρησης | |
| BRPI0618391A2 (pt) | método para identificar um nucleotìdeo individual, método para seqüenciar uma seqüência de ácido nucleico alvo, e, kit para seqüenciar um ácido nucleico | |
| BRPI0918670B8 (pt) | anticorpo | |
| ATE515488T1 (de) | Click-chemie zur herstellung von reportermolekülen | |
| ATE542903T1 (de) | Luciferase-biosensoren für camp | |
| CY1116482T1 (el) | Συνθεσεις και μεθοδοι για τη θεραπεια ογκων, ινωσης, και πνευμονικης κυψελιδικης πρωτεϊνωσης | |
| ATE533838T1 (de) | Verfahren zur verbesserten einführung von dna in bakterienzellen | |
| MX2015004610A (es) | Metodo para diagnostico, pronostico y tratamiento de metastasis de cancer de prostata usando c-maf. | |
| WO2009086215A3 (en) | Pathway analysis of cell culture phenotypes and uses thereof | |
| DE602006018709D1 (de) | Estergebundene geminitensidverbindungen zur verwendung in der gentherapie | |
| SG179561A1 (en) | Composition and method for imaging stem cells | |
| BR112014010448A2 (pt) | microorganismos e métodos para a produção de caprolactona | |
| ATE534738T1 (de) | Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen | |
| WO2009055823A3 (en) | Method to predict responsiveness of breast cancer to polyaminetype chemotherapy | |
| MX2008013397A (es) | Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos. |